Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
HIV Medicine|July 2, 2021
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participantsMathieu Chalouni, Linda Wittkop, Firouzé Bani-Sadr, et al.Journal of Hepatology|December 17, 2011
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIHDominique Salmon, Firouzé Bani-Sadr, Marc-Arthur Loko, et al.AIDS and Behavior|July 10, 2019
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)Melina Erica Santos, Camelia Protopopescu, Philippe Sogni, et al.Journal of Hepatology|August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related deathMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.HIV Medicine|August 17, 2021
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysisMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.Health Science Reports|December 8, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, et al.Journal of Hepatology|October 4, 2021
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitusVincent Mallet, Lucia Parlati, Alessandro Martinino, et al.Hepatology (Baltimore, Md.)|August 30, 2019
Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study)Tangui Barré, Camelia Protopopescu, Firouzé Bani-Sadr, et al.Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.Journal of Pediatric Gastroenterology and Nutrition|July 29, 2017
Cystic Fibrosis-related Liver Disease: Research Challenges and Future PerspectivesDominique Debray, Michael R Narkewicz, Frank A J A Bodewes, et al.Pageof 11